Media coverage about Welltower (NYSE:HCN) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Welltower earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 47.2448922497687 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the media headlines that may have effected Accern’s rankings:

Shares of Welltower (NYSE HCN) opened at $59.35 on Monday. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.76 and a current ratio of 1.76. Welltower has a 52 week low of $58.24 and a 52 week high of $78.17. The firm has a market capitalization of $22,439.92, a P/E ratio of 24.33, a price-to-earnings-growth ratio of 4.16 and a beta of 0.25.

Welltower (NYSE:HCN) last issued its quarterly earnings data on Tuesday, November 7th. The real estate investment trust reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.03. The company had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. Welltower had a return on equity of 7.45% and a net margin of 22.67%. The firm’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.16 earnings per share. equities analysts predict that Welltower will post 4.24 EPS for the current fiscal year.

Several analysts recently commented on HCN shares. Stifel Nicolaus cut their price objective on Welltower from $75.00 to $74.00 and set a “buy” rating for the company in a report on Friday, November 3rd. ValuEngine raised Welltower from a “hold” rating to a “buy” rating in a report on Saturday, January 13th. Stephens set a $70.00 price objective on Welltower and gave the stock a “buy” rating in a report on Friday, January 12th. Zacks Investment Research upgraded Welltower from a “sell” rating to a “hold” rating in a research report on Tuesday, January 23rd. Finally, SunTrust Banks set a $66.00 target price on Welltower and gave the company a “hold” rating in a research report on Monday, January 22nd. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the company. Welltower presently has a consensus rating of “Hold” and a consensus target price of $71.62.

In other Welltower news, Director Gary Whitelaw bought 1,420 shares of the business’s stock in a transaction dated Tuesday, November 21st. The shares were purchased at an average price of $68.39 per share, with a total value of $97,113.80. Following the completion of the purchase, the director now owns 1,420 shares in the company, valued at approximately $97,113.80. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.19% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Marea Informative and is the property of of Marea Informative. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at

About Welltower

Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.

Insider Buying and Selling by Quarter for Welltower (NYSE:HCN)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with's FREE daily email newsletter.